Skip to main content

CG Oncology, Inc 8-K, filed Nov 6, 2026

CG Oncology, Inc. (CGON)

8-K 2026-11-06 For: 2026-11-06
View Original
Added on November 06, 2026

About this 8-K

CG Oncology, Inc filed this 8-K on November 6, 2026.

CG Oncology reported a $56.9 million third-quarter net loss and expects PIVOT-006 Phase 3 topline data in November 2026, with $984.5 million in cash funding operations through 2029. AI summary

Items reported

  • Item 2.02: Financial results
  • Item 9.01: Financial statements and exhibits